Suicidal ideation / suicide Clinical Trials in Lebanon, NH
As of June 2026, 1 paid clinical trial is recruiting for Suicidal ideation / suicide in Lebanon, New Hampshire. Recruiting Suicidal ideation / suicide studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Lebanon
Filter results
1 clinical trial for Suicidal ideation / suicide
·Clear filters·↓ Download CSVAbout research studies in Lebanon
Lebanon has approximately 276 recruiting research studies across a wide range of therapeutic areas. New Hampshire hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Lebanon
Researchers run research studies in Lebanon, NH at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, B Acute Lymphoblastic Leukemia | 72 |
| Dartmouth-Hitchcock Medical Center | Neoplasm Metastasis, Trauma Injury, Aortic Stenosis | 72 |
| Dartmouth Hitchcock Medical Center | Multiple Myeloma, Amyotrophic Lateral Sclerosis, Epilepsy | 64 |
| Dartmouth Hitchcock | ALK Genomic Tumor Aberrations, Advanced Cancer, Advanced Solid Tumor | 8 |
| Dartmouth Cancer Center | Adjuvant Treatment, Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab | 5 |
| Dartmouth Health | Colorectal Adenoma, Colorectal Cancer, Colorectal Neoplasms | 5 |
| Dartmouth-Hitchcock | Leukemia, Myelodysplastic Syndromes, Myeloproliferative Syndrome | 3 |
| Dartmouth-Hitchcock Clinic | Breast Cancer, Fragility Fracture, Infant | 3 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Dartmouth Hitchcock Medical Center ( Site 0016) | Carcinoma, Non-Small-Cell Lung | 2 |
| Dartmouth-Health | Spastic Hemiparesis, Spinal Fusion, Spinal Stenosis | 2 |
| Dartmouth-Health Lebanon | Cognitive Dysfunction, Memory Disorders, Memory Dysfunction | 2 |
| Dartmouth-Hitchcock Clinics | Depression, Major Depressive Disorder, Obesity | 2 |
| 46 Centerra Parkway, Suite 300, Office #333S | Anxiety, Cannabis Use Disorder, Depression - Major Depressive Disorder | 1 |
| Alice Peck Day Memorial Hospital | Suicide Attempt, Suicide Ideation | 1 |
| Children's Hospital at Dartmouth: Geisel School of Medicine | Child, Critical Illness, Hospital Acquired Pressure Ulcer | 1 |
| Cinical Study Site | Chronic Inflammatory Demyelinating Polyneuropathy | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Darthmouth-Hitchcock Medical Center | Alzheimer Disease | 1 |
| Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center | Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer | 1 |
| Dartmouth Hitchcock Cancer Center | Advanced Melanoma | 1 |
| Dartmouth Hitchcock Clinics Heater Road | Pyoderma Gangrenosum | 1 |
| Dartmouth Hitchcock Clinics, Heater Road Primary Care | Colorectal Cancer Screening, Fecal Immunochemical Test | 1 |
| Dartmouth Hitchcock Med Ctr/Dartmouth Cancer Ctr | Leiomyosarcoma, Liposarcoma, Retroperitoneal Sarcoma | 1 |
| Dartmouth Hitchcock Medical Center - Old Etna Road /ID# 263840 | Atopic Dermatitis | 1 |
Active & Upcoming Studies in Lebanon (2026)
Recruiting trials in Lebanon grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (131 active studies)
- aPBI Re-irradiation · Phase 1, Phase 2 · Dartmouth-Hitchcock Medical Center
- Computer Guided Microwave Liver Ablation · NE Scientific INC
Neurology & pain (17 active studies)
- Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds · Phase 4 · Dartmouth-Hitchcock Medical Center
- Epileptiform Potential of Fully Immersive Virtual Reality · Dartmouth-Hitchcock Medical Center
Cardiovascular (10 active studies)
- Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease · Dartmouth-Hitchcock Medical Center
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Mental health & behavior (8 active studies)
- TF-CBT for Autistic Youth Pilot Implementation - Open Pilot · Dartmouth-Hitchcock Medical Center
- Evaluating the Impact of Psychotherapeutic Advertising Claims on Cannabis Purchasing · Trustees of Dartmouth College
Diabetes & metabolic (4 active studies)
- Pilot Trial of the Move Healthier Group · Dartmouth-Hitchcock Medical Center
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study · Phase 3 · Eli Lilly and Company
Pediatric (4 active studies)
- Video Inspired Discussions About Ethical Outcomes in Pediatrics · Massachusetts General Hospital
- Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research · Dartmouth-Hitchcock Medical Center
Vaccines (1 active study)
Common conditions studied in Lebanon
- Breast Cancer (7 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Acute Myeloid Leukemia (5 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Epilepsy (5 active studies). Epilepsy research focuses on new anti-seizure medications, neuromodulation devices, and precision therapies for genetic epilepsies.
- Multiple Myeloma (5 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Ulcerative Colitis (5 active studies). Ulcerative colitis trials examine biologic therapies, S1P receptor modulators, and oral small molecules for steroid-sparing remission.
- Amyotrophic Lateral Sclerosis (4 active studies). Recruiting Amyotrophic Lateral Sclerosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Lebanon
- Dartmouth-Hitchcock Medical Center
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in New Hampshire are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Hampshire research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Lebanon. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Lebanon
Hipa.ai aggregates every recruiting study in Lebanon from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Lebanon?
There are approximately 276 recruiting clinical trials in Lebanon, New Hampshire listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lebanon pay participants?
Most recruiting trials in Lebanon compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lebanon?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lebanon?
The most common conditions under active study in Lebanon include Breast Cancer (7), Acute Myeloid Leukemia (5), Epilepsy (5), Multiple Myeloma (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lebanon?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lebanon on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lebanon?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lebanon?
Recruiting research sites in Lebanon include Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Dartmouth Hitchcock Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lebanon right now?
The largest active categories in Lebanon are Cancer & tumors (131), Neurology & pain (17), Cardiovascular (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.